--- title: "IB Acquisition (IBAC) stock: news and investor profile" url: "https://aibio.space/companies/ib-acquisition/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "IB Acquisition Corp. (NASDAQ: IBAC), United States. Listing facts, related biotech companies and news on aibio.space." --- IBAC IB Acquisition Corp. NASDAQ · United States # IB Acquisition (IBAC) news IB Acquisition Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IBAC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. ## Latest IB Acquisition news We have not published a story on IB Acquisition yet. When there is news, it will appear here. ## IB Acquisition at a glance - **Ticker**: IBAC - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $30,161 ### Related companies - [ICON](https://aibio.space/companies/icon/) NASDAQ: ICLR - [Trulieve Cannabis](https://aibio.space/companies/trulieve-cannabis/) NYSE: TRLV - [Research Alliance Corp III](https://aibio.space/companies/research-alliance-iii/) NASDAQ: RACC - [Brainsway](https://aibio.space/companies/brainsway/) NASDAQ: BWAY - [Lifeloc Technologies](https://aibio.space/companies/lifeloc-technologies/) OTC: LCTC - [Apyx Medical](https://aibio.space/companies/apyx-medical/) NASDAQ: APYX - [SS Innovations International](https://aibio.space/companies/ss-innovations-international/) NASDAQ: SSII - [LENSAR](https://aibio.space/companies/lensar/) NASDAQ: LNSR ### Also on NASDAQ - [Schrodinger](https://aibio.space/companies/schrodinger/) SDGR - [MiniMed Group](https://aibio.space/companies/minimed/) MMED - [Wave Life Sciences](https://aibio.space/companies/wave-life-sciences/) WVE - [MiNK Therapeutics](https://aibio.space/companies/mink-therapeutics/) INKT - [TriSalus Life Sciences](https://aibio.space/companies/trisalus-life-sciences/) TLSI - [Vivani Medical](https://aibio.space/companies/vivani-medical/) VANI ## IB Acquisition annual financials | Line | FY ended Sep 30, 2025 | FY ended Sep 30, 2024 | |---|---|---| | Net income (loss) | [$3.4 million](https://www.sec.gov/Archives/edgar/data/1998781/000149315225029365/) | [$1.9 million](https://www.sec.gov/Archives/edgar/data/1998781/000149315225029365/) | | Cash from operations | [-$1.3 million](https://www.sec.gov/Archives/edgar/data/1998781/000149315225029365/) | [-$820,959](https://www.sec.gov/Archives/edgar/data/1998781/000149315225029365/) | | Cash and equivalents | [$428,700](https://www.sec.gov/Archives/edgar/data/1998781/000149315226038060/) | [$822,799](https://www.sec.gov/Archives/edgar/data/1998781/000149315225029365/) | Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $30,161. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about IB Acquisition What is the ticker symbol of IB Acquisition? IB Acquisition Corp. trades under the ticker IBAC on NASDAQ. Where is IB Acquisition listed? IB Acquisition Corp. is listed on NASDAQ. Which country or territory is IB Acquisition listed under? Our directory records IB Acquisition Corp. under United States. Does aibio.space cover IB Acquisition? aibio.space lists IB Acquisition Corp. among 2,820 public biotech companies and publishes its news here as stories appear. Is IB Acquisition profitable? IB Acquisition Corp. reported net income of $3.4 million for the fiscal year ended Sep 30, 2025, and used $1.3 million of cash in operations, per its annual report to the SEC. How much cash does IB Acquisition have? $30,161 in cash at Jun 30, 2026, per its 10-Q. ## Investor discussion: IB Acquisition Members talk about IB Acquisition (IBAC). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at IB Acquisition, newest first. Each line links the filing it comes from. 1. 2026-10-15 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 5.08,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1998781/000149315226047243/ex99-1.htm) 2. 2026-10-06 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1998781/000149315226045994/form8-k.htm) 3. 2026-07-24 Mergers Filed documents for a merger or acquisition. SEC Form S-4. [Source](https://www.sec.gov/Archives/edgar/data/1998781/000149315226034626/forms-4.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:IBAC on TradingView](https://www.tradingview.com/symbols/NASDAQ-IBAC/). ## Listing details IB Acquisition Corp. is a public biotech or pharmaceutical company listed on NASDAQ under the ticker IBAC, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: IB Acquisition Corp. - **Ticker**: IBAC - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/ib-acquisition/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "IB Acquisition (IBAC) stock: news and investor profile", 2026-10-31, https://aibio.space/companies/ib-acquisition/